BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7565955)

  • 1. Mitochondrial toxicity--new adverse drug effects.
    Swartz MN
    N Engl J Med; 1995 Oct; 333(17):1146-8. PubMed ID: 7565955
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.
    McKenzie R; Fried MW; Sallie R; Conjeevaram H; Di Bisceglie AM; Park Y; Savarese B; Kleiner D; Tsokos M; Luciano C
    N Engl J Med; 1995 Oct; 333(17):1099-105. PubMed ID: 7565947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe toxicity of fialuridine (FIAU).
    Lewis W; Perrino FW
    N Engl J Med; 1996 Apr; 334(17):1136; author reply 1137-8. PubMed ID: 8598881
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe toxicity of fialuridine (FIAU).
    Gordon M
    N Engl J Med; 1996 Apr; 334(17):1136-7; author reply 1137-8. PubMed ID: 8598883
    [No Abstract]   [Full Text] [Related]  

  • 5. NIH, FDA seek lessons from hepatitis B drug trial deaths.
    Macilwain C
    Nature; 1993 Jul; 364(6435):275. PubMed ID: 8332178
    [No Abstract]   [Full Text] [Related]  

  • 6. NIH panel report of 'no flaws' in FIAU trial at variance with FDA report, new probe planned.
    Marwick C
    JAMA; 1994 Jul; 272(1):9-11. PubMed ID: 8007087
    [No Abstract]   [Full Text] [Related]  

  • 7. Depletion of mitochondrial DNA, destruction of mitochondria, and accumulation of lipid droplets result from fialuridine treatment in woodchucks (Marmota monax).
    Lewis W; Griniuviene B; Tankersley KO; Levine ES; Montione R; Engelman L; de Courten-Myers G; Ascenzi MA; Hornbuckle WE; Gerin JL; Tennant BC
    Lab Invest; 1997 Jan; 76(1):77-87. PubMed ID: 9010451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection.
    Tennant BC; Baldwin BH; Graham LA; Ascenzi MA; Hornbuckle WE; Rowland PH; Tochkov IA; Yeager AE; Erb HN; Colacino JM; Lopez C; Engelhardt JA; Bowsher RR; Richardson FC; Lewis W; Cote PJ; Korba BE; Gerin JL
    Hepatology; 1998 Jul; 28(1):179-91. PubMed ID: 9657111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe toxicity of fialuridine (FIAU).
    Prince AM
    N Engl J Med; 1996 Apr; 334(17):1136; author reply 1137-8. PubMed ID: 8598882
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical course of four patients receiving the experimental antiviral agent fialuridine for the treatment of chronic hepatitis B infection.
    Stevenson W; Gaffey M; Ishitani M; McCullough C; Dickson R; Caldwell S; Lobo P; Pruett T
    Transplant Proc; 1995 Feb; 27(1):1219-21. PubMed ID: 7878856
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis study. Drug trial deaths deemed unavoidable.
    Marshall E
    Science; 1994 Jun; 264(5165):1530. PubMed ID: 8202706
    [No Abstract]   [Full Text] [Related]  

  • 12. Concern grows over reaction to deaths in clinical trials.
    Macilwain C
    Nature; 1994 May; 369(6478):268. PubMed ID: 8183354
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitochondrial injury. Lessons from the fialuridine trial.
    Honkoop P; Scholte HR; de Man RA; Schalm SW
    Drug Saf; 1997 Jul; 17(1):1-7. PubMed ID: 9258627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deaths in US fialuridine trial.
    Brahams D
    Lancet; 1994 Jun; 343(8911):1494-5. PubMed ID: 7911188
    [No Abstract]   [Full Text] [Related]  

  • 15. US health agencies at odds over trial deaths.
    Macilwain C
    Nature; 1994 Jun; 369(6480):433. PubMed ID: 8202125
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe toxicity of fialuridine (FIAU).
    Josephson L
    N Engl J Med; 1996 Apr; 334(17):1135-6; author reply 1137-8. PubMed ID: 8598880
    [No Abstract]   [Full Text] [Related]  

  • 17. Histopathologic changes associated with fialuridine hepatotoxicity.
    Kleiner DE; Gaffey MJ; Sallie R; Tsokos M; Nichols L; McKenzie R; Straus SE; Hoofnagle JH
    Mod Pathol; 1997 Mar; 10(3):192-9. PubMed ID: 9071726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for the anti-hepatitis B virus activity and mitochondrial toxicity of fialuridine (FIAU).
    Colacino JM
    Antiviral Res; 1996 Mar; 29(2-3):125-39. PubMed ID: 8739593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial deaths prompt tighter rules.
    Macilwain C
    Nature; 1993 Nov; 366(6453):294. PubMed ID: 8247116
    [No Abstract]   [Full Text] [Related]  

  • 20. Falsely low calcium measurements after high volume plasma exchange in a patient with liver failure.
    Miller JP; Mintz PD
    Transfus Sci; 1994 Sep; 15(3):299-302. PubMed ID: 10161259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.